about
Evolutionary and molecular facts link the WWC protein family to Hippo signalingMutant Gq/11 promote uveal melanoma tumorigenesis by activating YAPNf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG developmentProtein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactionsRegulation of TAZ in cancerThe Roles of NDR Protein Kinases in Hippo SignallingEnvironmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor CellsHedgehog Signaling in Pancreatic Fibrosis and CancerMechanisms of Hippo pathway regulationThe TEAD Family and Its Oncogenic Role in Promoting TumorigenesisCadherin signaling: keeping cells in touchEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief reviewHarnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenationThe emerging molecular machinery and therapeutic targets of metastasisThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentAtypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.Myosin Vb mediated plasma membrane homeostasis regulates peridermal cell size and maintains tissue homeostasis in the zebrafish epidermisTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyChromatin signaling in muscle stem cells: interpreting the regenerative microenvironmentRegulation of Long Bone Growth in Vertebrates; It Is Time to Catch UpMAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathwayHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerTumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivatorsComparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targetsThe Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling PathwaymiR-206 Mediates YAP-Induced Cardiac Hypertrophy and SurvivalWnt-YAP interactions in the neural fate of human pluripotent stem cells and the implications for neural organoid formationDLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domainMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation.Striatins contain a noncanonical coiled coil that binds protein phosphatase 2A A subunit to form a 2:2 heterotetrameric core of striatin-interacting phosphatase and kinase (STRIPAK) complex.Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.The Hippo-YAP signaling pathway and contact inhibition of growth.The role of the Hippo pathway in human disease and tumorigenesisEGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Angiomotins link F-actin architecture to Hippo pathway signaling.Novel insights into G protein and G protein-coupled receptor signaling in cancer
P2860
Q24293337-20C01A4E-495D-4104-B8F7-23A4623C9A2BQ24298571-351DDE69-71C1-49BA-9C64-F71954727477Q24307540-B1E41611-E599-4E01-BD17-7806C6B6E483Q24307997-F53EBB2F-FEC7-43F3-88FC-5B69849A7F8CQ26740462-30965C02-7678-44C8-A8E0-AE5EBEB497BEQ26746889-F44EC34B-E069-4976-AF2C-452D5A889D87Q26747621-36963C14-696A-44CD-97B1-75EE4C176EE4Q26766578-2A4D85E6-1CA8-4847-961B-E179329E8239Q26771285-B4054E91-2727-44BC-B534-C0D1BE2FFE0AQ26775126-8BF39DDE-D85B-4C4D-84D0-6C514F3E230DQ26784615-E6C2A73E-AFCA-4014-8531-0906EFD1BB4FQ26827810-738E742C-3354-4B53-AE66-B10ACCF31553Q26851371-BE9A0414-3E52-40C8-A95F-D85DCA9864C3Q26995264-CCDE9C21-E709-4C56-BC0C-C69582C293D0Q27022207-717DFD61-4949-4639-9439-A698C0880CABQ27025661-FB11C004-D564-422D-ADE1-F395AF488739Q27305890-F5C3C59A-AC07-43DB-9AD7-EA61BD1310D9Q27313515-453A6A53-E462-45D9-9543-990077F369C1Q28078129-5BA28694-6B5A-4979-8CB0-4A806E88321EQ28083474-18AEC217-C4B2-40EE-A32B-C2150451E2B2Q28083996-4D3FD22F-3D65-446D-A7ED-A50EDB2648AAQ28268117-9E64DA3F-3824-447D-9BCC-9140202E458CQ28269498-3F9A1DA4-E54B-472F-B39C-DC2CBC24D966Q28504464-0EE65CF9-65E0-496E-A20B-E86A703FA9A0Q28541360-FE277919-ADBA-4006-8DBB-780EB2C91FB7Q28546976-8089C0B4-2F9A-4EEA-AF57-91E16A6E2B70Q28579456-73CC2BF9-BCF7-4FC2-A814-1BA2EE06894CQ28973608-5F13C823-BD12-4EB7-B51A-8568A22DF6F8Q29871129-5A80462C-FD48-4775-8024-4A4D8068C0D7Q30275987-751ED53E-3795-4F7E-9B93-E06D86CDFF4AQ30354586-4B0E141C-9397-4120-A608-430FE1B74C10Q30354662-8A20708E-CDD4-4896-B29D-916ABFE32ACDQ30357501-BD5A6ED4-8D23-4A44-BAF6-5B641FBD3D49Q30359226-F74F1BA1-3073-4F8D-8AED-49741B73A4BAQ30368396-071D1E79-F19B-4E42-9320-FB0AA3E86A19Q30408095-A8A63215-F2F7-412F-9AF5-C04B7EE50A0EQ30433413-64E720BE-8A39-416E-ADEB-545B69BDE921Q33276007-B02DA8DB-8E90-42A1-968F-314256400AF8Q33604410-97EC3100-E8A1-46EE-8D06-7821A797861EQ33612895-FAA699F8-2982-4CFC-B0EC-3D661A6CBCA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Hippo pathway: regulators and regulations.
@en
type
label
The Hippo pathway: regulators and regulations.
@en
prefLabel
The Hippo pathway: regulators and regulations.
@en
P2860
P356
P1433
P1476
The Hippo pathway: regulators and regulations.
@en
P2093
Fa-Xing Yu
Kun-Liang Guan
P2860
P304
P356
10.1101/GAD.210773.112
P577
2013-02-01T00:00:00Z